Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Vaccine
|
March 8, 2025
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics
Giulia Dowgier, Agnieszka Hobbs, David Greenwood, et al.
Lancet (London, England)
|
March 14, 2024
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign
Marianne Shawe-Taylor, David Greenwood, Agnieszka Hobbs, et al.
Nature Microbiology
|
September 19, 2018
Mini viral RNAs act as innate immune agonists during influenza virus infection
Aartjan J W Te Velthuis, Joshua C Long, David L V Bauer, et al.
Plos Biology
|
January 21, 2025
Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasion
Harriet V Mears, George R Young, Theo Sanderson, et al.
The Lancet. Infectious Diseases
|
December 9, 2023
SARS-CoV-2 mucosal neutralising immunity after vaccination
Edward J Carr, Guilia Dowgier, David Greenwood, et al.
Plos One
|
March 21, 2024
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history
Hermaleigh Townsley, Joshua Gahir, Timothy W Russell, et al.
The Lancet. Infectious Diseases
|
September 14, 2024
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study
Timothy W Russell, Hermaleigh Townsley, Joel Hellewell, et al.
Lancet (London, England)
|
June 22, 2023
Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest London
Chris Bailey, Theo Sanderson, Hermaleigh Townsley, et al.
Lancet (London, England)
|
January 29, 2022
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer
Annika Fendler, Scott T C Shepherd, Lewis Au, et al.
Cancer Cell
|
April 28, 2023
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer
Mary Y Wu, Scott T C Shepherd, Annika Fendler, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Vaccine
|
March 8, 2025
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics
Giulia Dowgier, Agnieszka Hobbs, David Greenwood, et al.
Lancet (London, England)
|
March 14, 2024
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign
Marianne Shawe-Taylor, David Greenwood, Agnieszka Hobbs, et al.
Nature Microbiology
|
September 19, 2018
Mini viral RNAs act as innate immune agonists during influenza virus infection
Aartjan J W Te Velthuis, Joshua C Long, David L V Bauer, et al.
Plos Biology
|
January 21, 2025
Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasion
Harriet V Mears, George R Young, Theo Sanderson, et al.
The Lancet. Infectious Diseases
|
December 9, 2023
SARS-CoV-2 mucosal neutralising immunity after vaccination
Edward J Carr, Guilia Dowgier, David Greenwood, et al.
Plos One
|
March 21, 2024
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history
Hermaleigh Townsley, Joshua Gahir, Timothy W Russell, et al.
The Lancet. Infectious Diseases
|
September 14, 2024
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study
Timothy W Russell, Hermaleigh Townsley, Joel Hellewell, et al.
Lancet (London, England)
|
June 22, 2023
Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest London
Chris Bailey, Theo Sanderson, Hermaleigh Townsley, et al.
Lancet (London, England)
|
January 29, 2022
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer
Annika Fendler, Scott T C Shepherd, Lewis Au, et al.
Cancer Cell
|
April 28, 2023
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer
Mary Y Wu, Scott T C Shepherd, Annika Fendler, et al.
Page
of 4